| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/27/2007 | EP1799705A1 Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection |
| 06/27/2007 | EP1799262A2 Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders |
| 06/27/2007 | EP1799261A2 Methods and compositions for combinatoral-based production of multivalent recombinant antigens |
| 06/27/2007 | EP1799260A2 Anti- amyloid antibodies, compositions, methods and uses |
| 06/27/2007 | EP1799259A1 Binding molecules for treatment and detection of cancer |
| 06/27/2007 | EP1799257A1 The use of an inhibitor of heterotetrameric annexin 2 for treating viral infections |
| 06/27/2007 | EP1799256A2 Method of eliciting an immune response against hiv |
| 06/27/2007 | EP1799255A1 Recombinant human cytomegalovirus and vaccines comprising heterologous antigens |
| 06/27/2007 | EP1799254A1 Clostridial neurotoxins for use in tissue healing |
| 06/27/2007 | EP1799253A1 Multivalent canine vaccines against leptospira bratislava and other pathogens |
| 06/27/2007 | EP1799252A1 Antibody production method |
| 06/27/2007 | EP1799251A2 Chimeric phage-derived particles, methods for their production and use |
| 06/27/2007 | EP1799243A2 Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway |
| 06/27/2007 | EP1355936B1 Polymer conjugates of neublastin and methods of using same |
| 06/27/2007 | EP1305419B1 Modulation by il-tif/interleukin-21 |
| 06/27/2007 | EP1220923B1 FACTOR IX/FACTOR IXa ACTIVATING ANTIBODIES |
| 06/27/2007 | EP1121436B1 Non-desensitizing ampa-receptors |
| 06/27/2007 | EP1107986B1 Protein domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 and methods of making and using the same |
| 06/27/2007 | EP0980387B1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays |
| 06/27/2007 | EP0954340B1 Targeted combination immunotherapy of cancer |
| 06/27/2007 | EP0851870B1 Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides |
| 06/27/2007 | EP0817853B1 Infectious dna clone of the tick-borne encephalitis (tbe) virus; recombinant vaccine derived from the said clone and production of the said vaccine; and a pharmaceutical product containing a replicable nucleic acid |
| 06/27/2007 | CN1989410A Immune response assessment method |
| 06/27/2007 | CN1989250A Tc-83-derived alphavirus vectors, particles and methods |
| 06/27/2007 | CN1989240A Vaccine comprising an attenuated pestivirus |
| 06/27/2007 | CN1989154A Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform |
| 06/27/2007 | CN1989149A Cynomolgus prostate specific antigen |
| 06/27/2007 | CN1988918A Multiple-variable dose regimen for treating tnfalpha-related disorders |
| 06/27/2007 | CN1988917A Phep, an amino acid permease of staphylococcus aureus |
| 06/27/2007 | CN1986811A Japanese blood fluke epiderm gene and its coded protein and application |
| 06/27/2007 | CN1986808A Japanese blood fluke specific epiderm gene and protein and their application |
| 06/27/2007 | CN1986807A Japanese blood fluke epidermal antigen gene and protein and their application |
| 06/27/2007 | CN1986806A Japanese blood fluke epidermal antigen gene and protein and their application |
| 06/27/2007 | CN1986805A Specific protein gene and protein of female blood fluke and their application |
| 06/27/2007 | CN1986804A Japanese blood fluke specific epiderm gene and its coded protein and application |
| 06/27/2007 | CN1986803A Japanese blood fluke epiderm gene and its coded protein and application |
| 06/27/2007 | CN1986802A Japanese blood fluke epidermal antigen gene and its coded protein and application |
| 06/27/2007 | CN1986798A Japahese blood fluke epidermal antigen gene and its coded protein and application |
| 06/27/2007 | CN1986797A Japanese blood fluke epidermal antigen gene and its coded protein and application |
| 06/27/2007 | CN1986569A Humanized respiratory syncytial virus-resisting neutralizing gentically engineered Fab antibody |
| 06/27/2007 | CN1986562A Polypeptide segment capable of enhancing animal's antibody response and its application |
| 06/27/2007 | CN1985992A New scheme of combining cell factor fusion protein (IL 2/FC) and compound Chinese medicine 861 for enhancing immune response of HB vaccine and breaking immune tolerance of HBV |
| 06/27/2007 | CN1323167C Muteins of placental growth factor type 1, preparing method and application thereof |
| 06/27/2007 | CN1323162C Paramycobacterial diagnostics and vaccines |
| 06/27/2007 | CN1323088C Method for producing tetanic immunoglobulin |
| 06/27/2007 | CN1322897C Use of IL-18 inhibitors |
| 06/26/2007 | US7235644 Vaccine against Gram-negative bacterial infections |
| 06/26/2007 | US7235637 IL-1 eta DNA and polypeptides |
| 06/26/2007 | US7235632 for diagnosing malignant and benign hemopathies; isolated human cell surface protein wherein said protein; expressed at the surface of human lymphoid progenitor cells and mature NK cells |
| 06/26/2007 | US7235534 Oligonucleotide or polynucleotide for treating vascular healing after surgery, preventing atherosclerotic plaque, vein graft healing, cardiovascular disorders |
| 06/26/2007 | US7235529 Brain-associated inhibitor of tissue-type plasminogen activator |
| 06/26/2007 | US7235522 Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
| 06/26/2007 | US7235395 Lactic acid bacteria as agents for treating and preventing allergy |
| 06/26/2007 | US7235392 Transforming B lymphocytes with Epstein-Barr virus, incubating transformed B lymphocytes with flavin N-oxide photosensitizer, adding non-toxic antioxidant, and exposing lymphocytes to activator such as photoradiation to activate photosensitizer |
| 06/26/2007 | US7235380 CDR-grafted anti-tissue factor antibodies and methods of use thereof |
| 06/26/2007 | US7235372 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 06/26/2007 | US7235371 Human osteoclast derived cathepsin |
| 06/26/2007 | US7235368 CHP for use as marker for sepsis-type inflammatory diseases |
| 06/26/2007 | US7235246 Dermatomycosis vaccine |
| 06/26/2007 | US7235245 Chimeric lyssavirus nucleic acids and polypeptides |
| 06/26/2007 | US7235244 Compositions and methods for treating papillomavirus-infected cells |
| 06/26/2007 | US7235243 Immunological combination compositions and methods |
| 06/26/2007 | US7235242 use as a carrier for a conjugate, particularly in combination with a polysaccharide, and a process for producing the peptide as well as vaccines comprising said peptide |
| 06/26/2007 | US7235240 A mutein of IL-15 at least one deletion or substitution in two positions of the amino acid sequence; transplant rejection, autoimmune diseases, inflammatory bowel disease, skin disorders, gatrointestinal disorders, vision defects; antiarthritic, anticarcinogenic, and antidiabetic agents |
| 06/26/2007 | US7235239 Antibodies to a chemokine expressed in inflamed adenoid |
| 06/26/2007 | US7235238 Antibodies that bind receptor protein designated 2F1 |
| 06/26/2007 | US7235235 Alphavirus RNA replicon systems |
| 06/26/2007 | US7235232 Interferon alpha hybrids |
| 06/26/2007 | CA2295316C Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy |
| 06/26/2007 | CA2216827C Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein |
| 06/26/2007 | CA2157118C Isolation of components of interest from milk |
| 06/26/2007 | CA2154445C Lysosomal targeting of immunogens |
| 06/26/2007 | CA2139862C Use of p97 and iron binding proteins as diagnostic and therapeutic agents |
| 06/26/2007 | CA2065797C Monoclonal antibody, polypeptide and production thereof |
| 06/23/2007 | CA2571800A1 Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction |
| 06/21/2007 | WO2007070856A2 Method for treating immune dysfunction by regulation of cd40 ligand expression |
| 06/21/2007 | WO2007070750A1 Anti-il-17 antibodies |
| 06/21/2007 | WO2007070678A2 Rabies vaccine |
| 06/21/2007 | WO2007070659A2 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 06/21/2007 | WO2007070629A2 Porphyromonas gingivalis 1435/1449 lps as an immune modulator |
| 06/21/2007 | WO2007070538A2 Anti-mn antibodies and methods of using same |
| 06/21/2007 | WO2007070430A2 Identification and application of antibiotic synergy |
| 06/21/2007 | WO2007069795A1 Method for prevention of tumor |
| 06/21/2007 | WO2007069709A1 Detecting agent and therapeutic agent for highly malignant breast cancer |
| 06/21/2007 | WO2007069368A1 Peptides originating in hepatitis c virus |
| 06/21/2007 | WO2007069204A2 Antiviral, virucid and immunomodulant officinal plant-based composition and related method for the treatment of viral diseases, in particular of hiv infection. |
| 06/21/2007 | WO2007068907A2 Vaccine compositions comprising a saponin adjuvant |
| 06/21/2007 | WO2007068895A1 Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer |
| 06/21/2007 | WO2007068747A1 Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| 06/21/2007 | WO2007068497A1 An adjuvant system comprising virosomes and liposomes |
| 06/21/2007 | WO2007068485A2 Biological materials and uses thereof |
| 06/21/2007 | WO2007068429A1 Antibodies against amyloid beta 4 with glycosylated in the variable region |
| 06/21/2007 | WO2007068412A2 A beta 1-42 specific monoclonal antibodies with therapeutic properties |
| 06/21/2007 | WO2007068411A2 Therapeutic vaccine |
| 06/21/2007 | WO2007068354A1 Means and methods for the treatment of tumorous diseases |
| 06/21/2007 | WO2007068255A1 Use of effector-function-deficient antibodies for treatment of auto-immune diseases |
| 06/21/2007 | WO2007068154A1 A method for preparing specific igy against mutant avian influenza virus and the preparation tηereof |
| 06/21/2007 | WO2007068058A1 Hyper immune bovine colostrum gastrointestinal vaccine |
| 06/21/2007 | WO2007068055A1 A method for preventing reduced feed intake in animals and treatment of disease conditions |
| 06/21/2007 | WO2007050359A3 Anti-addl monoclonal antibody and use thereof |